Expanded as FEK Advisory LLC in 2017 after two decade of accounting and assurance services. We are a boutique accounting and business advisory services firm providing fractional CFO and controller services to clients in the technology, higher education and non-profit industries.

‪‎elected chairman July 2024Epidermolysis Bullosa (EB) — "The Worst Disease You've Never Heard Of."​ The Dystrophic Epidermolysis Bullosa Research Association of America (debra of America), founded in 1980, is the only U.S. nonprofit providing all-inclusive support to the EB Community, through funding research for a cure and by providing free programs and services for those with EB. WHAT IS EB?EB is a rare genetic connective tissue disorder in which individuals do not produce a vital protein that allows their skin to adhere to itself. It is present in 1 out of every 20,000 live births in the U.S. EB afflicts both genders and all racial and ethnic backgrounds equally. The most prominent manifestation of EB is blistering or tearing of the skin from the slightest touch or friction, which causes patients to live with constant pain and scarring. Because their skin is so fragile, they are often known as "Butterfly Children."​ Taking off a shirt or even receiving a hug is incredibly painful and causes the skin to peel away. Internal organs and bodily systems can also be seriously affected by EB, and the worst forms lead to eventual disfigurement, disability, and often early death. Treatment is supportive and includes daily wound care, bandaging, and pain management. While there is currently no cure for EB, scientists around the world are dedicating their energies to developing life-changing treatments, in addition to finding a cure.

EB Research Partnership grew out of collaboration between the Jackson Gabriel Silver Foundation and Heal EB, two organizations that were founded by families on separate coasts that shared a singular goal: to find a cure for their sons, and all others that suffer from EB. With support from close friends Jill and Eddie Vedder, the lead singer of Pearl Jam, EB Research Partnership (EBRP) was founded in 2014.EB Research Partnership is the largest 501(c)(3) nonprofit dedicated to funding research aimed at treating and ultimately curing Epidermolysis Bullosa, a group of devastating and life-threatening skin disorders that affect children from birth. EB Research Partnership works to treat and cure EB as quickly and efficiently as possible and fulfills their mission by partnering with non-profit and for-profit organizations, foundations, individual donors, and the EB and research communities.EB Research Partnership utilizes an innovative business model of venture philanthropy, leveraging concepts from principal investing and applying them towards achieving philanthropic goals. When making a grant to a research project, they retain the added upside of generating a recurring donation stream if the therapy or product is commercially successful, then use this revenue to fund additional EB research. To learn more about EB Research Partnership visit www.ebresearch.org.

Part of 2015 asset sale from Corinthian College Inc (NYSE: COCO)

Considerable experience relating to the accounting and auditing issues facing private companies, with and emphasis in the venture backed software and technology companies. Mohler, Nixon & Williams combined with Moss Adams in 2013 and is now their Technology office.

(NYSE: MAGI) Controller & Director of Accounting responsible for all aspects of accounting department and financial reporting. Completed reverse merger to purchase the company off the NYSE and to the Kinkade Family. Post merger I consolidated all of Thomas Kinkade's legal entities, ventures and properties, including a working ranch, into JDEdwards. I left to go back into public accounting but obtained the company as an audit client, while at Mohler, Nixon, Williams CPAs.

Plan, execute and complete multiple client engagements of varying size and complexity, including special projects, carve-out audits, acquisition audits and registration statements.